Philip C Huang

Philip C Huang has extensive experience in the healthcare and biotechnology industries. Philip C is currently the Chief Executive Officer of Pharus Diagnostics, a position they have held since 2022. Prior to that, they worked at Roche, where they served as the Vice President of Partnering Hub- APAC from 2020 to 2022 and as the Head of Partnering Hub, Asia-Pacific from 2016 to 2020.

Before joining Roche, Philip held the role of Vice President Of Global Business Development at EKF Diagnostics from 2014 to 2016. At EKF Diagnostics, they were responsible for the development, manufacture, and distribution of point of care diagnostics for various medical conditions.

Earlier in their career, Philip worked at Moksha8 Pharmaceuticals as the Director of Corporate Development, focusing on funding and partnership deals with pharmaceutical and biotech companies. Philip C also gained experience at Illumina as part of the founding technical support operations team in Asia and at Hikma Pharmaceuticals as a Business Development Manager & Acting China Country Manager.

Philip's experience also includes positions at Danaher Corporation, Affymetrix, ESI BIO - A Division of BioTime, Inc., and Caliper Life Sciences. In these roles, they gained valuable expertise in marketing, research and development, and applications support.

Overall, Philip C Huang has a diverse and impressive work history in the healthcare and biotechnology sectors, demonstrating their expertise in leadership, business development, and strategic partnerships.

Philip C Huang has a Bachelor of Science (BS) degree in Chemical Engineering from the Massachusetts Institute of Technology. Philip C also obtained a Master of Science (MS)/Engineer degree in Chemical Engineering and Management Science & Engineering from Stanford University. Additionally, they have an MBA degree in General Management from INSEAD and a Master of Business Administration (MBA) degree in Business Administration and Management, General from The Wharton School.